1. CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50. Issue 1 (27th November 2020) Authors: Ozawa, Yuichi; Harutani, Yuhei; Oyanagi, Jun; Akamatsu, Hiroaki; Murakami, Eriko; Shibaki, Ryota; Hayata, Atsushi; Sugimoto, Takeya; Tanaka, Masanori; Takakura, Toshiaki; Furuta, Katsuyuki; Okuda, Yuka; Sato, Kouichi; Teraoka, Shunsuke; Ueda, Hiroki; Tokudome, Nahomi; Kitamura, Yuka; Fukuoka, Jun... Journal: Cancer science Issue: Volume 112:Issue 1(2021) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of Systemic Inflammatory Response Syndrome and quick Sequential Organ Failure Assessment scores in predicting bacteremia in the emergency department. Issue 1 (1st May 2021) Authors: Furuta, Katsuyuki; Akamatsu, Hiroaki; Sada, Ryuichi; Miyamoto, Kyohei; Teraoka, Shunsuke; Hayata, Atsushi; Ozawa, Yuichi; Nakanishi, Masanori; Koh, Yasuhiro; Yamamoto, Nobuyuki Journal: Acute medicine & surgery Issue: Volume 8:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab. (January 2018) Authors: Sato, Koichi; Akamatsu, Hiroaki; Murakami, Eriko; Sasaki, Seigo; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Koh, Yasuhiro; Ueda, Hiroki; Nakanishi, Masanori; Yamamoto, Nobuyuki Journal: Lung cancer Issue: Volume 115(2018) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71–74]. (December 2018) Authors: Sato, Koichi; Akamatsu, Hiroaki; Murakami, Eriko; Sasaki, Seigo; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Koh, Yasuhiro; Ueda, Hiroki; Nakanishi, Masanori; Yamamoto, Nobuyuki Journal: Lung cancer Issue: Volume 126(2018) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system. (30th January 2020) Authors: Ikeda, Mio; Koh, Yasuhiro; Teraoka, Shunsuke; Sato, Koichi; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Hiroaki; Ozawa, Yuichi; Akamatsu, Keiichiro; Endo, Katsuya; Higuchi, Masayuki; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki Journal: Cancer medicine Issue: Volume 9:Number 6(2020) Page Start: 2122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dual Chemical Modification of a Polytheonamide Mimic: Rational Design and Synthesis of Ion‐Channel‐Forming 48‐mer Peptides with Potent Cytotoxicity. Issue 10 (2nd February 2016) Authors: Hayata, Atsushi; Itoh, Hiroaki; Matsutaka, Shoko; Inoue, Masayuki Journal: Chemistry Issue: Volume 22:Issue 10(2016) Page Start: 3370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer. (19th November 2019) Authors: Akamatsu, Hiroaki; Murakami, Eriko; Oyanagi, Jun; Shibaki, Ryota; Kaki, Takahiro; Takase, Eri; Tanaka, Masanori; Harutani, Yuhei; Yamagata, Nao; Okuda, Yuka; Furuta, Katsuyuki; Sugimoto, Takeya; Teraoka, Shunsuke; Hayata, Atsushi; Tokudome, Nahomi; Ozawa, Yuichi; Mori, Keita; Koh, Yasuhiro; Yamam... Journal: Oncologist Issue: Volume 25:Number 4(2020) Page Start: e679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib. (17th April 2022) Authors: Shibaki, Ryota; Ozawa, Yuichi; Noguchi, Susumu; Murakami, Yusuke; Takase, Eri; Azuma, Yuichiro; Maebeya, Masaru; Sugimoto, Takeya; Hayata, Atsushi; Hayakawa, Takahiro; Tamaki, Shinya; Nakanishi, Masanori; Teraoka, Shunsuke; Akamatsu, Hiroaki Journal: Cancer medicine Issue: Volume 11:Number 20(2022) Page Start: 3743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors. Issue 5 (17th March 2020) Authors: Kurimoto, Chiaki; Inaba, Hidefumi; Ariyasu, Hiroyuki; Iwakura, Hiroshi; Ueda, Yoko; Uraki, Shinsuke; Takeshima, Ken; Furukawa, Yasushi; Morita, Shuhei; Yamamoto, Yuki; Yamashita, Shimpei; Katsuda, Masahiro; Hayata, Atsushi; Akamatsu, Hiroaki; Jinnin, Masatoshi; Hara, Isao; Yamaue, Hiroki; Akamizu... Journal: Cancer science Issue: Volume 111:Issue 5(2020) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab. (June 2019) Authors: Oyanagi, Jun; Koh, Yasuhiro; Sato, Koichi; Mori, Keita; Teraoka, Shunsuke; Akamatsu, Hiroaki; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki Journal: Lung cancer Issue: Volume 132(2019) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗